INVO Bioscience, Inc. announced that on March 31, 2023, Jeffrey Segal MD submitted his resignation as a director of the Company. Dr. Segal's resignation was not because of any disagreements with the Company on matters relating to its operations, policies and practices.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 USD | -2.67% | -7.69% | -46.67% |
15/05 | INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
18/04 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-46.67% | 28.57L | |
-4.98% | 18TCr | |
+0.23% | 11TCr | |
-3.78% | 6.79TCr | |
-6.26% | 4.65TCr | |
+10.87% | 4.58TCr | |
+6.38% | 4.25TCr | |
+19.84% | 3.08TCr | |
+16.53% | 2.61TCr | |
-3.51% | 2.39TCr |
- Stock Market
- Equities
- INVO Stock
- News INVO Bioscience, Inc.
- INVO Bioscience, Inc. Announces Resignation of Jeffrey Segal as A Director